Ticker ARA – American Renal Associates – sales, description, marketcap – Tickerday.com

ARA

American Renal Associates

–

Index: NYSE; Sector: Healthcare; Industry: Healthcare Facilities;

Marketcap: 237.76M; Volume: 30.84K; AvgVol 3m: 63.21K; Beta: 1.62;

Cost estimate:

P/E: –; EPS: -0.33; EPS growth quarter/prev quarter: 104.60%;

EPS growth this year: 31.10%; EPS growth past 5 years: -26.50%;

EPS ttm: -0.33;

P/S: 0.30; P/B: ; P/Cashflow: 1.86; P/FCF: 1.52;

Sales: 815.84M; Sales growth quarter/prev quarter: -3.80%; Sales growth past 5 years: 8.00%;

Profitability:

Gross Margin: 25.20%; Profit Margin: -1.30%; Operating Margin: 7.40%;

ROA – return on assets: -0.90%; ROE – return on equity: 13.20%; LT Debt/Equity: ; Total Debt/Equity: ;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 5.80%; Insider Transactions:0.00%;

Institutional Ownership: 82.40%; Institutional Transactions: -3.10%;

Data update: 07/10/2020.